These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2243894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K, Tsuchida K, Kanzaki A, Ujike H, Hamamura T, Kondo K, Mutoh S, Miyanagi K, Kuroda S, Otsuki S.
    Biol Psychiatry; 1995 Nov 15; 38(10):639-48. PubMed ID: 8555375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
    Chang WH, Chen TY, Lin SK, Lung FW, Lin WL, Hu WH, Yeh EK.
    Biol Psychiatry; 1990 Mar 01; 27(5):510-8. PubMed ID: 2310806
    [Abstract] [Full Text] [Related]

  • 6. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J.
    Biol Psychiatry; 1993 Oct 15; 34(8):523-8. PubMed ID: 8274579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
    Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY.
    Psychiatry Res; 1997 Mar 24; 69(2-3):113-21. PubMed ID: 9109179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Haloperidol response and plasma catecholamines and their metabolites.
    Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ.
    Schizophr Res; 1993 Jun 24; 10(1):33-7. PubMed ID: 8369230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
    Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY.
    Biol Psychiatry; 1997 Mar 01; 41(5):560-6. PubMed ID: 9046988
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma homovanillic acid as a predictor of response to neuroleptics.
    Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ.
    Arch Gen Psychiatry; 1988 Jun 01; 45(6):564-7. PubMed ID: 3377643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.